Evidence mapPaperPMID 19942084Full record

ReviewJournal of the American College of Cardiology2009

Inflammation in atherosclerosis: from pathophysiology to practice.

Peter Libby, Paul M Ridker, Göran K Hansson, Leducq Transatlantic Network on Atherothrombosis

6 registry-linked trialsAbstract readReview
In one paragraph

Review in Journal of the American College of Cardiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 963 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
963citing papers in PubMed, 3 pooled it
45.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02428374 phase4unknown statusstarted 2015, after this paper: background citation

Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study (B And T Types of Lymphocytes Evaluation in Acute Myocardial Infarction)

Ran2015Enrolled300Registered outcomes30Posted comparisons0ConditionsMyocardial FibrosisArmsRosuvastatin plus clopidogrel, Rosuvastatin plus ticagrelor, Simvastatin plus clopidogrel, Simvastatin plus ticagrelor
Open the trial in the graph
NCT02399384 completednot on this mapstarted 2015, after this paper: background citation

Myocardial Adipose Inflammation and Pericardial Adipose Volume as Markers for Coronary Artery Disease In HIV Positive Patients

TypeobservationalSponsorUniversity of CincinnatiRan2015 to 2018Enrolled12ConditionsCoronary Artery Disease, Human Immunodeficiency Virus (HIV)
NCT02543502 nacompletednot on this mapstarted 2012, after this paper: background citation

Treatment of Periodontal Disease in Patients With Acute Myocardial Infarction: Randomized Controlled Trial

TypeinterventionalSponsorInstituto de Cardiologia do Rio Grande do SulRan2012 to 2015Enrolled54ConditionsPeriodontitisArmsperiodontal treatment
NCT02644239 naunknown statusnot on this mapstarted 2012, after this paper: background citation

Classic Ketogenic Diet and Modified: Evaluation of the Therapeutic Potential and Impact on the Oxidative Profile, Lipidomic, Inflammatory and Size of Lipoproteins in Children and Adolescents With Refractory Epilepsy

TypeinterventionalSponsorUniversity of Sao PauloRan2012 to 2020Enrolled60ConditionsEpilepsy, Cardiovascular Disease, Non-alcoholic Fatty Liver Disease, Quality of LifeArmsketogenic diet
NCT03516903 phase2 / phase3terminatednot on this mapstarted 2018, after this paper: background citation

Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After ST-elevation Myocardial Infarction

TypeinterventionalSponsorUniversity of Sao PauloRan2018 to 2020Enrolled35ConditionsMyocardial Infarction, Anterior Wall, Myocardial Remodeling, VentricularArmsMethotrexate, Placebo, Folic Acid
NCT04046172 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Treatment of Periodontal Disease in Systemic Lupus Erytematosus: A Pilot Randomized Controlled Clinical Trial

TypeinterventionalSponsorUniversity College, LondonRan2021 to 2023Enrolled200ConditionsSystemic Lupus Erythematosus, PeriodontitisArmssupra/sub gingival root surface debridement, supra-gingival scaling and polishing
3 · Its place in the literature

Who cites it

963 citing papers in PubMed, 3 syntheses or guidelines pooled it, 2,133 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Low-Dose Colchicine for Secondary Prevention in Patients With Chronic Coronary Syndrome: A Multicenter Real-World Study.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Observational
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Thromboembolic events in giant cell arteritis: a scoping review.Annals of medicine and surgery (2012) · 2026
    Review
  20. Article

903 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Peter LibbyDivision of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA. plibby@rics.bwh.harvard.edu
Paul M Ridker
Göran K Hansson
Leducq Transatlantic Network on Atherothrombosis
Brigham and Women's Hospital · USKarolinska University Hospital · SE

Funding

Tissue AnalysesP01HL048743 · BRIGHAM AND WOMEN'S HOSPITAL · 1992 to 2005
$9.0M
Translational Program of Excellence in NanotechnologyU01HL080731 · MASSACHUSETTS GENERAL HOSPITAL · 2005 to 2005
$1.9M
Determinants of Arterial Remodeling in AtherogenesisR01HL080472 · BRIGHAM AND WOMEN'S HOSPITAL · 2005 to 2005
$406k
NHLBI NIH HHS P01 HL048743NHLBI NIH HHS R01 HL080472NHLBI NIH HHS U01 HL080731
6 · The paper itself

Abstract

Until recently, most envisaged atherosclerosis as a bland arterial collection of cholesterol, complicated by smooth muscle cell accumulation. According to that concept, endothelial denuding injury led to platelet aggregation and release of platelet factors which would trigger the proliferation of smooth muscle cells in the arterial intima. These cells would then elaborate an extracellular matrix that would entrap lipoproteins, forming the nidus of the atherosclerotic plaque. Beyond the vascular smooth muscle cells long recognized in atherosclerotic lesions, subsequent investigations identified immune cells and mediators at work in atheromata, implicating inflammation in this disease. Multiple independent pathways of evidence now pinpoint inflammation as a key regulatory process that links multiple risk factors for atherosclerosis and its complications with altered arterial biology. Knowledge has burgeoned regarding the operation of both innate and adaptive arms of immunity in atherogenesis, their interplay, and the balance of stimulatory and inhibitory pathways that regulate their participation in atheroma formation and complication. This revolution in our thinking about the pathophysiology of atherosclerosis has now begun to provide clinical insight and practical tools that may aid patient management. This review provides an update of the role of inflammation in atherogenesis and highlights how translation of these advances in basic science promises to change clinical practice.

Indexed as

AtherosclerosisInflammationAnticholesteremic AgentsCell ProliferationCholesterolHumansHydroxymethylglutaryl-CoA Reductase InhibitorsImmunity, InnateMuscle, Smooth, VascularPlatelet AggregationAnticholesteremic AgentsCholesterolHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID19942084
PMCPMC2834169
OpenAlexW1552829599

What Socratic holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.